UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A dominant vimentin variant causes a rare syndrome with premature aging

European journal of human genetics : EJHG, 2020-09, Vol.28 (9), p.1218-1230

2020

Volltextzugriff (PDF)

Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1)

Stem cell research, 2022-04, Vol.60, p.102721-102721, Article 102721

2022

Volltextzugriff (PDF)

APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants

International journal of molecular sciences, 2022-04, Vol.23 (8), p.4281

2022

Volltextzugriff (PDF)

Update on methodologies available for ciguatoxin determination: perspectives to confront the onset of ciguatera fish poisoning in Europe

Marine Drugs, 2010-06, Vol.8 (6), p.1838-1907

2010

Volltextzugriff (PDF)

Generation of an induced pluripotent stem cell line (ITXi012-A) from a patient with genetically determined high-lipoprotein(a) plasma levels

Stem cell research, 2023-10, Vol.72, p.103205-103205, Article 103205

2023

Volltextzugriff (PDF)

Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome

Journal of the American Heart Association, 2015-09, Vol.4 (9), p.e002159-e002159

2015

Volltextzugriff (PDF)

Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system

Stem cell research, 2022-01, Vol.58, p.102627-102627, Article 102627

2022

Volltextzugriff (PDF)

Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia

Disease models & mechanisms, 2016-01, Vol.9 (1), p.81-90

2016

Volltextzugriff (PDF)

Generation of human induced pluripotent stem cell lines from four unrelated healthy control donors carrying European genetic background

Stem cell research, 2022-03, Vol.59, p.102647-102647, Article 102647

2022

Volltextzugriff (PDF)

FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells

STAR protocols, 2022-12, Vol.3 (4), p.101680-101680, Article 101680

2022

Volltextzugriff (PDF)

Human induced pluripotent stem cells‐derived liver organoids grown on a Biomimesys® hyaluronic acid‐based hydroscaffold as a new model for studying human lipoprotein metabolism

Bioengineering & translational medicine, 2024-07, Vol.9 (4), p.e10659-n/a

2024

Volltextzugriff (PDF)

Evaluation of seafood toxicity in the Australes archipelago (French Polynesia) using the neuroblastoma cell-based assay

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2013-03, Vol.30 (3), p.567-586

2013

Volltextzugriff (PDF)

Monitoring of dissolved ciguatoxin and maitotoxin using solid-phase adsorption toxin tracking devices: Application to Gambierdiscus pacificus in culture

Harmful Algae, 2011-07, Vol.10 (5), p.433-446

2011

Volltextzugriff (PDF)

Human Induced Pluripotent Stem Cells in Hepatology

The American journal of pathology, 2014-02, Vol.184 (2), p.332-347

2014

Volltextzugriff (PDF)

Human induced pluripotent stem cells in hepatology: beyond the proof of concept

The American journal of pathology, 2014-02, Vol.184 (2), p.332-47

2014

Volltextzugriff (PDF)

Deletions in the 3’UTR of the LDLR gene: A genetic cause of familial hypobetalipoproteinemia

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

Gambierdiscus excentricus sp. nov. (Dinophyceae), a benthic toxic dinoflagellate from the Canary Islands (NE Atlantic Ocean)

Harmful Algae, 2011-11, Vol.11, p.10-22

2011

Volltextzugriff (PDF)

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis

Haematologica (Roma), 2023-11, Vol.108 (11), p.3068-3085

2023

Volltextzugriff (PDF)

Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia

Circulation (New York, N.Y.), 2022-09, Vol.146 (10), p.724-739

2022

Volltextzugriff (PDF)

Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotyping screening - application on metabolic diseases

Journal of hepatology, 2020-08, Vol.73, p.S244

2020

Volltextzugriff (PDF)

THU209 - Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotyping screening - application on metabolic diseases

Journal of hepatology, 2020-08, Vol.73, p.S244-S244

2020

Volltextzugriff (PDF)

Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile

Arteriosclerosis, thrombosis, and vascular biology, 2022-10, Vol.42 (10), p.1262-1271

2022

Volltextzugriff (PDF)

PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs

Stem cell reports, 2021-12, Vol.16 (12), p.2958-2972

2021

Volltextzugriff (PDF)

Les organoïdes hépatiques: Quels sont les enjeux ?

M.S. Médecine sciences, 2021-10, Vol.37 (10), p.902-909

2021

Volltextzugriff (PDF)

Hepatic organoids: What are the challenges?

M.S. Médecine sciences, 2021-10, Vol.37 (10), p.902

2021

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)

Sprache

Englisch
(29)
Französisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A dominant vimentin variant causes a rare syndrome with premature aging

Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1)

APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants

Update on methodologies available for ciguatoxin determination: perspectives to confront the onset of ciguatera fish poisoning in Europe

Generation of an induced pluripotent stem cell line (ITXi012-A) from a patient with genetically determined high-lipoprotein(a) plasma levels

Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome

Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system

Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia

Generation of human induced pluripotent stem cell lines from four unrelated healthy control donors carrying European genetic background

FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells

Human induced pluripotent stem cells‐derived liver organoids grown on a Biomimesys® hyaluronic acid‐based hydroscaffold as a new model for studying human lipoprotein metabolism

Evaluation of seafood toxicity in the Australes archipelago (French Polynesia) using the neuroblastoma cell-based assay

Monitoring of dissolved ciguatoxin and maitotoxin using solid-phase adsorption toxin tracking devices: Application to Gambierdiscus pacificus in culture

Human Induced Pluripotent Stem Cells in Hepatology

Human induced pluripotent stem cells in hepatology: beyond the proof of concept

Deletions in the 3’UTR of the LDLR gene: A genetic cause of familial hypobetalipoproteinemia

Gambierdiscus excentricus sp. nov. (Dinophyceae), a benthic toxic dinoflagellate from the Canary Islands (NE Atlantic Ocean)

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis

Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia

Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotyping screening - application on metabolic diseases

THU209 - Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotyping screening - application on metabolic diseases

Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile

PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs

Les organoïdes hépatiques: Quels sont les enjeux ?

Hepatic organoids: What are the challenges?

Suchergebnisse filtern